Good Life Plus PLC - Issue of CLNs, £275,000 Raised
Announcement provided by
Good Life Plus Plc · GDLF02/09/2024 10:00
Good Life Plus Plc
(the "Company" or "Good Life Plus")
Issue of Convertible Loan Notes
Good Life Plus Plc (AQSE: GDLF), an innovator in the luxury prize draw and rewards sector, is pleased to announce it has raised
The CLNs will expire on 31 August 2025 and carry a coupon of 10% which will be paid in cash quarterly in arrears. On maturity, and at the Company's discretion, the CLNs will either be repaid in full with a 10% bonus paid in cash on top of the principal or will convert at a 10% discount to the trailing 30 day VWAP at the time of maturity.
In addition, there will be an automatic conversion of the CLNs in the intervening period should the Company conduct an equity raise of
The participation of Winforton constitutes a related party transaction under Rule 4.6 of the AQSE Growth Market Access Rulebook. The Directors consider that having exercised reasonable care, skill and diligence, the related party transaction is fair and reasonable as far as the shareholders of the Company are concerned.
This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).
The Directors of the Company take responsibility for this announcement.
-Ends-
For further information please contact:
Good Life Plus Plc +44 (0)7500 929157
Charlie Chadd, Chief Executive
Novum Securities Limited
AQSE Corporate Advisor
David Coffman / Daniel Harris / George Duxberry 44 (0)20 7399 9400
Financial Media and Investor Communications
John West / Lily Pearce + 44 (0)20 7653 8702
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.